Marker Therapeutics, Inc.

10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Amended charter or bylaws; Shareholder vote results May 4, 2026 8-K Results of operations (earnings release) Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Item 5.08 Feb 9, 2026 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Director or officer change; Other events Nov 5, 2025 8-K Other events Oct 6, 2025 8-K Regulation FD disclosure Aug 26, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Changed accountants Aug 12, 2025 8-K Entered a material agreement; Other events Jun 17, 2025 8-K Shareholder vote results Jun 9, 2025 8-K Other events May 20, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Shareholder vote results Mar 27, 2025 8-K/A Director or officer change; Other events Mar 4, 2025 8-K Director or officer change; Other events Feb 19, 2025 8-K Director or officer change Jan 30, 2025 8-K Entered a material agreement; Unregistered sale of equity Dec 23, 2024 8-K Entered a material agreement; Other events Dec 19, 2024 8-K Other events Dec 17, 2024 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Other events Aug 12, 2024 8-K Shareholder vote results; Other events Jun 12, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Other events Apr 8, 2024 8-K Results of operations (earnings release) Mar 26, 2024 10-K Fiscal year ended 2023-12-31 Mar 26, 2024 8-K Terminated a material agreement Mar 1, 2024 8-K Entered a material agreement Feb 26, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Other events Dec 11, 2023